Science Explorer Back to mapMap
Discussion
Researcher · Epic Sciences (United States) · United States

David Bourdon

David Bourdon publishes mostly in Oncology, Molecular Biology and Cancer Research, on topics such as Cancer Genomics and Diagnostics, Cancer Cells and Metastasis and Protein Kinase Regulation and GTPase Signaling.

OpenAlex
World rank
#3,555,906
of 7,710,434 ranked researchers
Rank in United States
#991,982
of 1,627,098
Works
31
Citations
1.1k
Citations per work
35.9
h-index
6
i10-index 6Top 84% in Oncology
David Bourdon

What does David Bourdon research?

David Bourdon's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (32%), Neuroscience (5%).

Life Sciences: 11 works · 37.0% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 32.1% of their workMolecular Biology: 6 works · 18.5% of their workCancer Research: 4 works · 13.6% of their workNeuroscience: 2 works · 4.9% of their workCellular and Molecular Neuroscience: 2 works · 4.9% of their workHealth Sciences: 10 works · 33.3% of their workMedicine: 10 works · 33.3% of their workOncology: 6 works · 19.8% of their workPulmonary and Respiratory Medicine: 3 works · 8.6% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 4.9% of their workEverything else: 9 works · 29.7% of their workTHEIR WORKDavid Bourdon31works
Life Sciences37%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1032.1%
    2. Neuroscience24.9%
    1. Medicine1033.3%
  3. Everything else929.7%
  1. 1Oncology20% of their works
  2. 2Molecular Biology18% of their works
  3. 3Cancer Research14% of their works
  4. 4Pulmonary and Respiratory Medicine9% of their works
  5. 5Cellular and Molecular Neuroscience5% of their works
  6. 6Radiology, Nuclear Medicine and Imaging5% of their works

Research topics

Which keywords describe David Bourdon's research?

The keywords of their largest research topics: Cancer Genomics, Mutational Signatures, Cancer Stem Cells, Tumor Metastasis, Androgen Receptor, Neuropeptides, Prostate Cancer and Protein Kinases.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Cancer Genomics91 topic
  2. Mutational Signatures91 topic
  3. Cancer Stem Cells71 topic
  4. Tumor Metastasis71 topic
  5. Androgen Receptor31 topic
  6. Neuropeptides31 topic
  7. Prostate Cancer31 topic
  8. Protein Kinases31 topic
  9. Ras Signaling31 topic
  10. Receptors31 topic
  11. Bioactive Compounds21 topic
  12. Crystal Structure21 topic
  13. G-Protein-Coupled Receptors21 topic
  14. Quantitative21 topic
  15. Real-Time PCR21 topic
  16. Seaweed21 topic

Where does David Bourdon work?

David Bourdon's main affiliation in the publication record is Epic Sciences (United States), United States.

How many publications and citations does David Bourdon have?

OpenAlex counts 31 works and 1,112 citations for David Bourdon, an h-index of 6, ranking #3,555,906 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David Bourdon. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.